Skip to main content

Advertisement

Log in

Diffuse large B-cell lymphoma arising from donor lymphoid cells after renal and pancreatic transplantation

  • Case Report
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

A patient with both a renal and pancreatic transplantation developed a diffuse large B-cell lymphoma, Epstein-Barr virus-related, 14 months after the surgical procedure. Tumor was confined to the transplanted organs: head of the pancreas and hilar lymph node of the transplanted kidney. Chimerism analysis demonstrated the tumor origin from donor lymphoid cells. Immunosuppression was discontinued and chemotherapy with cyclophosphamide, hydroxydaunomycin, vincristine, and prednisone (CHOP) was started. However, no response was observed after three courses of this regimen. Finally, a transplantectomy was carried out, followed by rituximab (anti-CD20 antibody), with the patient achieving a complete response (CR). Two years later the patient remains in CR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1A–B.
Fig. 2.
Fig. 3A–D.
Fig. 4A–E.

Similar content being viewed by others

References

  1. Chadburn A, Suciu-Foca N, Cesarman E et al. (1995) Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. Am J Pathol 147:1862–1870

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Bustillo M, Perez Melon C, Otero Glz A et al. (2000). High grade lymphoma in a post-renal transplant patient. Description of a case and literature review (letter). Nephron 84:189–191

    Article  CAS  PubMed  Google Scholar 

  3. Swinnen LJ (2000) Diagnosis and treatment of transplant-related lymphoma. Ann Oncol 11[Suppl 1]:45–48

    Article  PubMed  Google Scholar 

  4. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987–994

    Article  Google Scholar 

  5. Ziegle JS, Su Y, Corcoran et al. (1992) Application of automated DNA sizing technology for genotyping microsatellite loci. Genomics 15:1026–1031

    Article  Google Scholar 

  6. Pfeffer PF (1999) Cancer in organ transplanted patients. Tidsskr Nor Laegeforen 119:3792–3794

    CAS  PubMed  Google Scholar 

  7. Penn I (2000) Cancers in renal transplant recipients. Adv Ren Replace Ther 7:147–156

    Article  CAS  PubMed  Google Scholar 

  8. Shapiro RS, McClain K, Frizzera G et al. (1988) Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234–1243

    CAS  PubMed  Google Scholar 

  9. Zutter MM, Martin PJ, Sale GE et al. (1988) Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520–529

    CAS  PubMed  Google Scholar 

  10. Swerdlow SH (1997) Classification of post-transplant lymphoproliferative disorders: from past to present. Semin Diagn Pathol 14 [Suppl 1]:2–7

    CAS  PubMed  Google Scholar 

  11. Gaidano G, Dalla-Favera R (2000) Pathobiology of non-Hodgkin lymphomas. In: Hoffman R, Benz EJ Jr, Shattil SJ et al. (eds) Hematology: basic principles and practice, 3rd edn. Churchill Livingstone, Philadelphia, p 1224

  12. Armitage JM, Kormos RL, Stuart RS et al. (1991) Posttransplant lymphoproliferative disease in thoracic organ transplant patients: 10 years of cyclosporine-based immunosuppression. J Heart Lung Transplant 10:877–886

    CAS  PubMed  Google Scholar 

  13. Cesarman E, Chadburn A, Liu YF et al. (1998) BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. Blood 92:2294–2302

    CAS  PubMed  Google Scholar 

  14. Benkerrou M, Jais JP, Leblond V et al. (1998) Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. Blood 92:3137–3147

    CAS  PubMed  Google Scholar 

  15. Grillo-Lopez AJ, White CA, Varns C et al. (1999) Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. Semin Oncol 26 [Suppl 14]:66–73

    CAS  PubMed  Google Scholar 

  16. Schilder R (1999) Rituximab immunotherapy. Cancer Biother Radiopharm 14 [Suppl 4]:237–240

  17. White CA (1999) Rituximab immunotherapy for non Hodgkin's lymphoma. Cancer Biother Radiopharm 14 [Suppl 4]:241–250

    Article  CAS  PubMed  Google Scholar 

  18. Kosits C, Callaghan M (2000) Rituximab: a new monoclonal antibody therapy for non-Hodgkin's lymphoma. Oncol Nurs Form 27 [Suppl 1]:51–59

    CAS  Google Scholar 

  19. Milpied N, Vasseur B, Parquet N et al. (2000) Humanized anti-CD20 monoclonal antibody (Rituximab) in post-transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Ann Oncol 11 [Suppl 1]:113–116

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This paper has been supported in part by a grant provided by "Marathon TV3, 1999", a nonprofit project raising funds for research in medicine, and FIS no. 00/946 from the Spanish Ministry of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Lopez-Guillermo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cibeira, M.T., Lopez-Guillermo, A., Colomer, D. et al. Diffuse large B-cell lymphoma arising from donor lymphoid cells after renal and pancreatic transplantation. Ann Hematol 82, 131–135 (2003). https://doi.org/10.1007/s00277-002-0591-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-002-0591-z

Keywords

Navigation